The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we did from my lab published the first paper that used a microbial opsin to get light sensitivity but it was as it turned out quite a a close call we published the paper from my lab in in 2005 and that came out in the summer of 2005. within six months several other papers came out uh they all were submitted right after ours was was published
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.